PT Kimia Farma (Persero) Tbk (KAEF.JK)
IDR 396.0
(0.51%)
IDR 396.0
(0.51%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 972.97 Billion IDR | -42.93% |
| 2022 | 1704.94 Billion IDR | -47.52% |
| 2021 | 3248.75 Billion IDR | 25.27% |
| 2020 | 2593.48 Billion IDR | 2.74% |
| 2019 | 2524.25 Billion IDR | 36.74% |
| 2018 | 1846.08 Billion IDR | 108.24% |
| 2017 | 886.52 Billion IDR | 134.71% |
| 2016 | 377.71 Billion IDR | 17147.8% |
| 2015 | 2.18 Billion IDR | -98.92% |
| 2014 | 203.09 Billion IDR | 10743.52% |
| 2013 | 1.87 Billion IDR | -70.69% |
| 2012 | 6.38 Billion IDR | 18.71% |
| 2011 | 5.38 Billion IDR | 15.57% |
| 2010 | 4.65 Billion IDR | -14.57% |
| 2009 | 5.45 Billion IDR | 0.0% |
| 2008 | - IDR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 1170.51 Billion IDR | 106.1% |
| 2024 Q3 | 2471.04 Billion IDR | 118.75% |
| 2024 Q1 | 697.41 Billion IDR | -33.22% |
| 2023 FY | 972.97 Billion IDR | -42.93% |
| 2023 Q4 | 972.97 Billion IDR | -11.25% |
| 2023 Q3 | 1096.31 Billion IDR | -29.21% |
| 2023 Q2 | 1548.58 Billion IDR | -6.52% |
| 2023 Q1 | 1656.55 Billion IDR | -2.84% |
| 2022 Q1 | 3105.47 Billion IDR | -4.41% |
| 2022 Q4 | 1704.94 Billion IDR | -47.23% |
| 2022 FY | 1704.94 Billion IDR | -47.52% |
| 2022 Q2 | 2937.49 Billion IDR | -5.41% |
| 2022 Q3 | 3230.91 Billion IDR | 9.99% |
| 2021 Q2 | 3178.89 Billion IDR | -3.76% |
| 2021 FY | 3248.75 Billion IDR | 25.27% |
| 2021 Q1 | 3303 Billion IDR | 27.36% |
| 2021 Q4 | 3248.75 Billion IDR | 10.17% |
| 2021 Q3 | 2948.92 Billion IDR | -7.23% |
| 2020 Q4 | 2593.48 Billion IDR | 5.48% |
| 2020 FY | 2593.48 Billion IDR | 2.74% |
| 2020 Q3 | 2458.7 Billion IDR | -1.51% |
| 2020 Q2 | 2496.38 Billion IDR | -20.2% |
| 2020 Q1 | 3128.49 Billion IDR | 23.94% |
| 2019 Q4 | 2524.25 Billion IDR | -13.96% |
| 2019 FY | 2524.25 Billion IDR | 36.74% |
| 2019 Q1 | 1899.31 Billion IDR | 2.88% |
| 2019 Q2 | 1882.82 Billion IDR | -0.87% |
| 2019 Q3 | 2933.97 Billion IDR | 55.83% |
| 2018 Q2 | 1708.47 Billion IDR | 8.22% |
| 2018 FY | 1846.08 Billion IDR | 108.24% |
| 2018 Q1 | 1578.64 Billion IDR | 78.07% |
| 2018 Q4 | 1846.08 Billion IDR | 4.32% |
| 2018 Q3 | 1769.56 Billion IDR | 3.58% |
| 2017 Q3 | 852.16 Billion IDR | 120.87% |
| 2017 Q2 | 385.82 Billion IDR | -13.91% |
| 2017 Q1 | 448.16 Billion IDR | 18.65% |
| 2017 FY | 886.52 Billion IDR | 134.71% |
| 2017 Q4 | 886.52 Billion IDR | 4.03% |
| 2016 Q3 | 302.99 Billion IDR | 10009.98% |
| 2016 Q4 | 377.71 Billion IDR | 24.66% |
| 2016 Q1 | 2.18 Billion IDR | 0.0% |
| 2016 Q2 | 2.99 Billion IDR | 36.85% |
| 2016 FY | 377.71 Billion IDR | 17147.8% |
| 2015 Q2 | 202.72 Billion IDR | -0.51% |
| 2015 Q1 | 203.76 Billion IDR | 0.33% |
| 2015 FY | 2.18 Billion IDR | -98.92% |
| 2015 Q3 | 202.72 Billion IDR | 0.0% |
| 2015 Q4 | 2.18 Billion IDR | -98.92% |
| 2014 Q4 | 203.09 Billion IDR | 32702.91% |
| 2014 Q3 | 619.13 Million IDR | -61.29% |
| 2014 Q2 | 1.59 Billion IDR | 0.0% |
| 2014 Q1 | 1.59 Billion IDR | -14.61% |
| 2014 FY | 203.09 Billion IDR | 10743.52% |
| 2013 Q2 | 1.99 Billion IDR | -29.2% |
| 2013 Q4 | 1.87 Billion IDR | 7.92% |
| 2013 FY | 1.87 Billion IDR | -70.69% |
| 2013 Q3 | 1.73 Billion IDR | -13.1% |
| 2013 Q1 | 2.82 Billion IDR | -55.86% |
| 2012 Q3 | 6.93 Billion IDR | 2.27% |
| 2012 Q4 | 6.38 Billion IDR | -7.85% |
| 2012 Q1 | 6.23 Billion IDR | 15.75% |
| 2012 FY | 6.38 Billion IDR | 18.71% |
| 2012 Q2 | 6.78 Billion IDR | 8.82% |
| 2011 FY | 5.38 Billion IDR | 15.57% |
| 2011 Q4 | 5.38 Billion IDR | 0.0% |
| 2010 FY | 4.65 Billion IDR | -14.57% |
| 2009 FY | 5.45 Billion IDR | 0.0% |
| 2008 FY | - IDR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| PT Enseval Putera Megatrading Tbk. | 2.36 Billion IDR | -41036.183% |
| PT Itama Ranoraya Tbk | 502.93 Million IDR | -193358.423% |
| PT Millennium Pharmacon International Tbk | 44 Billion IDR | -2111.317% |
| PT Soho Global Health Tbk | 9.44 Billion IDR | -10206.986% |